Spasmodic dysphonia in a patient with the A to G transition at nucleotide 8344 in mitochondrial DNA

Movement Disorders

Volumn 18, Issue 6, 2003, Pages 716-718

  Peng, Ying ^a   Crumley, Roger ^a   Ringman, John M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Botulinum toxin; Coenzyme Q10; Dystonia; Larynx; MERRF; Mithochondria; Myoclonic epilepsy; Myoclonus; Myopathy; Ragged red fibers; Spasmodic dysphonia; Speech; Valproic acid

Indexed keywords

ADENINE; BOTULINUM TOXIN; GUANINE; MITOCHONDRIAL DNA; NUCLEOTIDE; TRANSFER RNA; TRIHEXYPHENIDYL; UBIDECARENONE; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG RESPONSE; DYSPHONIA; FEMALE; GENE MUTATION; HUMAN; LARYNGOSCOPY; MERRF SYNDROME; MYOCLONUS; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPASMODIC DYSPHONIA;

DNA, MITOCHONDRIAL; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; MIDDLE AGED; MITOCHONDRIAL DISEASES; MUTATION; MYOCLONUS; PEDIGREE; STATISTICS, NONPARAMETRIC; VOICE DISORDERS;

EID: 0038422204     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10428     Document Type: Article

References (18)

1. Lera G, Bhatia K, Marsden CD. Dystonia as the major manifestation of Leigh's syndrome. Mov Disord 1994;9:642-649.
2. Kirby DM, Kahler SG, Freckmann ML, Reddihough D, Thorburn DR. Leigh disease caused by the mitochondrial DNA G14459A mutation in unrelated families. Ann Neurol 2000;48:102-104.
3. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-1430.
4. Novotny EJ Jr, Singh G, Wallace DC, Dorfman LJ, Louis A, Sogg RL, Steinman L. Leber's disease and dystonia: a mitochondrial disease. Neurology 1986;36:1053-1060.
5. Sudarsky L, Plotkin GM, Logigian EL, Johns DR. Dystonia as a presenting feature of the 3243 mitochondrial DNA mutation. Mov Disord 1999;14:488-491.
6. Silvestri G, Ciafaloni E, Santorelli FM, Shanske S, Servidei S, Graf WD, et al. Clinical features associated with the A to G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 1993;43:1200-1206.
7. lys mitochondrial mutation. Neurology 1998;51:1447-1450.
8. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 1990;61:931-937.
9. Chinnery PF, Turnbull DM. Epidemiology and treatment of mitochondrial disorders. Am J Med Genet 2001;106:94-101.
10. Blitzer A, Brin MF, Fahn S, Lovelace RE. Clinical laboratory characteristics of focal laryngeal dystonia: study of 110 cases. Laryngoscope 1988;98:636-640.
11. Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 1976;85:451-459.
12. Truong DD, Rontal M, Rolnick M, Aronson AE, Mistura K. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991;101:630-634.
13. Pool KD, Freeman FJ, Finitzo T, Hayashi MM, Chapman SB, Devous MD, et al. Heterogeneity in spasmodic dysphonia-neurologic and voice findings. Arch Neurol 1991;48:305-209.
14. Shoffner JM, Brown MD, Stugard C, et al. Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation in a complex I subunit. Ann Neurol 1995;38:163-169.
15. Koehler CM, Leuenberger D, Merchant S, Renold A, Junne T, Schatz G. Human deafness dystonia syndrome is a mitochondrial disease. Proc Nat Acad Sci U S A 1999;96:1817-1819.
16. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JS, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-671.
17. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira HV. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996;39:385-389.
18. Wallace DC. Mitochondrial disease in man and mouse. Science 1999;283:1482-1488.